Friday, October 24, 2025
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO North America > CEO Life > Health > More and more workers are using weight loss drugs. It’s costing their employers a fortune

More and more workers are using weight loss drugs. It’s costing their employers a fortune

in Health
More and more workers are using weight loss drugs. It’s costing their employers a fortune
Share on LinkedinShare on WhatsApp

Weight loss drugs are proving to be super popular among many workers with job-based health insurance. But GLP-1 medications are busting their employers’ budgets, leading some firms to rethink their coverage.

The share of very large firms covering these drugs for obesity soared to 43% this year, up from 28% last year, according to KFF’s latest annual Employer Health Benefits Survey, which was released on Wednesday. These employers, who have more than 5,000 workers, are much more likely than their smaller counterparts to offer such a benefit.

Among firms with between 200 and 999 staffers, only 16% provide coverage of drugs for weight loss this year, the same as last year, according to KFF, a nonpartisan health policy research group.

GLP-1 drugs, which treat diabetes, obesity and certain other conditions, have been in great demand since they came on the market a few years ago because they help patients shed pounds. While employers typically cover the medications for diabetes, fewer of them do so for weight loss, in part because of the drugs’ high prices — which have also limited Americans’ access to them. The list price of Wegovy, for instance, is about $1,350 for a month’s supply, though discounts are available.

Employers, however, recognize that covering the medications for weight loss is a valuable benefit to attract and retain talented staffers. Notably, even among firms that don’t do so, nearly half said the benefit is “very important” or “important” for employee satisfaction. More than 36 million people with job-based insurance have a body mass index that would medically qualify them for a GLP-1 drug.

“Large employers know these new high-priced weight-loss drugs are an important benefit for their workers, but their costs often exceed their expectations,” Gary Claxton, KFF senior vice president, said in a statement. “It’s not a surprise that some are rethinking access to the drugs for weight loss.”

Rising premiums

GLP-1 drug costs – and prescription drug prices in general – are also contributing to a rise in premiums.

Annual insurance coverage for a family hit $27,000, on average, this year, up 6% from 2024, according to KFF’s survey. Workers contribute $6,850 toward the cost, on average, while employers pick up the rest of the tab.

Meanwhile, individual coverage topped $9,300, on average, this year, up 5% – with employees shouldering $1,440 of the cost and employers paying the rest.

Over the past five years, the growth in premiums has been largely in line with inflation and wage increases.

But coverage for 2026 could be much pricier, according to several benefits consulting firms. KFF also points to GLP-1 medications, hospital prices and tariffs as factors that could push up premiums and out-of-pocket costs for workers next year.

Read the full article by CNN

Related Posts

Baking Soda Skin Care Hacks: Why Experts Say to Avoid These Viral Trends
Health

Baking Soda Skin Care Hacks: Why Experts Say to Avoid These Viral Trends

The silent killer increases your risk of stroke and dementia. Here’s how to control it
Health

The silent killer increases your risk of stroke and dementia. Here’s how to control it

Artificial sweeteners aged the brain by over 1.5 years, study says
Health

Artificial sweeteners aged the brain by over 1.5 years, study says

Nearly Half of Those With Diabetes Don’t Know They Have the Disease
Health

Nearly Half of Those With Diabetes Don’t Know They Have the Disease

Type 2 diabetes prevented with adherence to Mediterranean diet and exercise, study finds
Health

Type 2 diabetes prevented with adherence to Mediterranean diet and exercise, study finds

Sugary Drinks Increase Hair Loss Risk, but These Nutrients Can Help
Health

Sugary Drinks Increase Hair Loss Risk, but These Nutrients Can Help

Early signs of dementia can show in your finances
Health

Early signs of dementia can show in your finances

Unhappy With Your Company’s Health Insurance? Your Employer May Not Care.
Health

Unhappy With Your Company’s Health Insurance? Your Employer May Not Care.

Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Health

Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Extreme heat is miserable and dangerous. It’s also making us age faster
Health

Extreme heat is miserable and dangerous. It’s also making us age faster

No Result
View All Result

Recent Posts

  • Exploring Ephesus: A Greek Legacy in Modern-Day Turkey
  • The Louvre Heist: How Did Thieves Steal $102 M. in Jewels?
  • More and more workers are using weight loss drugs. It’s costing their employers a fortune
  • Intel’s streak continues as stocks rise after Q3 earnings
  • Trump pardons founder and former CEO of Binance

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.